Combining Aspirin With Cilostazol or Clopidogrel in Minor Stroke or TIA

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 870 participants.

Also called NCT06591299

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 870 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06591299
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Egypt (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT06591299. Randomized; double masking; primary purpose treatment. Start 2022-04-15 (actual); primary completion 2024-09-15 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Combining Aspirin With Cilostazol or Clopidogrel in Minor Stroke or TIA
Intervention (Drug)
Cilostazol 100 MG
Intervention (Drug)
Clopidogrel 75mg
Lead sponsor
Kafrelsheikh University (class: other)

Record details

Record id
cardio:ct-nct06591299
Content hash
a2e2a39265be0e32f3dc1c6be86bc3f330d8cda0a0c223d4b70450b676725e53